|
The
Strategies continues...
Growing through acquisitions
The large and emerging domestic market is attracting Fortune 500
companies, across sectors, to grow through acquisitions of incumbent
Indian companies, to get a quick presence. The following are some
examples of companies growing through acquisitions:
| » |
Following its global strategy of growth
through acquisitions, Pfizer India has acquired businesses in
India as well, resulting in growth and augmentation of its capabilities.
|
| » |
BASF has consolidated its presence in India by
making certain strategic acquisitions. It acquired Dr Beck India's
original equipment manufacturing (OEM) division, making it a
significant producer of OEM coatings and industrial coatings.
BASF also acquired the polystyrene business of the Chatterjee
Group in 2000. |
| » |
Lafarge increased its presence in India through
the acquisition route, by buying the cement business of Tata
Steel and then following it with the acquisition of Raymond's
cement facility. |
Anticipating a boom in retail banking
in India, HSBC acquired the Non-Fund Activities from Gujarat Lease
Financing Ltd in 1999. In the year 2000, the bank acquired the Chandigarh
branch license from Deutsche Bank. In 2002, the bank acquired retail
banking business from BNP Paribas and the retail banking operations
in Kolkata from Bank of Tokyo-Mitsubishi. Currently HSBC has 37
branches across 18 cities.
Clinical trials
India's large geographic spread, varied climatic conditions and
rich biodiversity make it one of the best places in the world for
conducting clinical research on a variety of health conditions.
Examples of some companies leveraging this advantage include:
| » |
Pfizer is using its Indian facility
for clinical studies. The company has invested $12.5 million
since 1995 in India on clinical trials. |
| » |
GlaxoSmithKline PLC's leveraging of India's process
chemistry skills, product development capability and manufacturing
strengths. For GSK, India's rich biodiversity and doctor base,
make it a promising clinical-trials destination for GSK innovations.
GSK conducts high-end statistical data analysis for clinical
trials from its center in India. |
|
